June 16 (Reuters) - Dyne Therapeutics Inc DYN.O:
DYNE THERAPEUTICS TO HOST INVESTOR CONFERENCE CALL AND WEBCAST TO PROVIDE UPDATE ON DYNE-101 FOR MYOTONIC DYSTROPHY TYPE 1, TOMORROW TUESDAY, JUNE 17 AT 8:00 A.M. ET
Source text: ID:nGNXc9p5l9
Further company coverage: DYN.O
((Reuters.Briefs@thomsonreuters.com;))